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Computational methods have complemented experimental and clinical neursciences and led to improvements
in our understanding of the nervous systems in health and disease. In parallel, neuromodulation in form of
electric and magnetic stimulation is gaining increasing acceptance in chronic and intractable diseases. In this
paper, we firstly explore the relevant state of the art in fusion of both developments towards translational
computational neuroscience. Then, we propose a strategy to employ the new theoretical concept of dynamical
network biomarkers (DNB) in episodic manifestations of chronic disorders. In particular, as a first example,
we introduce the use of computational models in migraine and illustrate on the basis of this example the
potential of DNB as early-warning signals for neuromodulation in episodic migraine.
I. FROM BIFURCATION TO BENCH AND BEDSIDE
The mathematical theory of bifurcations is part of
dynamical systems theory, which can straightforwardly
be applied to neurological and psychiatric diseases with
episodic manifestations. The term ‘bifurcation’ in this
context refers to abrupt changes of brain dynamics
when some physiological parameter values are smoothly
changed and, at a critical point—the bifurcation point—
the qualitative structure of the dynamical behavior
changes towards these new pathological dynamics. When
physiological control is lost in such a scenario, the patho-
logical process is called a dynamical disease1. Epilepsy
is the best studied neurological dynamical disease where
the theoretical concepts of bifurcation theory have been
translated to animal models (bench) and clinical studies
(bedside)2.
The theory of such bifurcations, or “tipping points”3,
complements experimental and clinical neurosciences
with mathematical analysis and simulations to interpret
data and guide a principle understanding of the nervous
systems in health and disease. One particular interest
is in defining dynamical network biomarkers (DNB) as
early-warning signals based on an analytical understand-
ing of the behavior at the imminent tipping point4–7. We
will focus on this in this paper and firstly extend this con-
cept to obtain a framework for a systematic evaluation of
the subtle symptoms that often occur in the prodromal
phase before the main episodic manifestations of chronic
a)dahlem@physik.hu-berlin.de
disorders. In a second step, we suggest to use DNB be-
yond monitoring early-warning signals and explore ways
in which DNB can lead to biofeedback signals in a control
paradigm for episodic treatment.
One central aim in translational computational neuro-
science is to fuse dynamical systems theory with control
theory8 and drive innovation in therapeutic brain stimu-
lation in neurological and psychiatric diseases with theo-
retical concepts. At this stage, let us only name two fur-
ther dynamical diseases other than epilepsy2, firstly (i),
Parkinson’s disease, which we do not further explore but
see Ref.9 and, secondly (ii), primary headaches, which
we set the focus on in this paper. In these dynamical
diseases, theoretical concepts are used (i) to illuminate
the role of the coupling architecture and abnormal ac-
tivity patterns in the subthalamopallidal network of the
basal ganglia and with that knowledge to explain the
mechanisms underlying the therapeutic efficacy of deep
brain stimulation in Parkinson’s disease10,11, and (ii) to
understand the dynamics of pain as a process of central
sensitisation in the migraine generator network and de-
fine neuromodulation targets and stimulation protocols
for episodic migraine treatment12 that possibly can also
be explored for neuromodulation in cluster headache13,
though we will focus mostly on migraines.
A brief note on the history is due. Despite the fact that
the fields of translational computational neuroscience
and neuromodulation are still in their relative infancy, let
alone their fusion, they both actually have a long partly
overlapping history. Neuromodulation for example in
form of non-drug treatment in headache dates back to
the mid-first century CE to Scribonius Largus, a physi-
cian who practiced at the court of the Roman Emperor
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FIG. 1. Schematic illustration of the dynamical features of disease progression from a normal state to a disease state through a
pre-disease state (modified from Ref.4). (a) The normal state is a steady state or a minimum of a potential function, representing
a relatively healthy stage. (b) The pre-disease state is situated immediately before the ‘tipping point’. At this stage, the system
is sensitive to external stimuli and still reversible to the normal state when appropriately interfered with. A small change in
the parameters of the system may suffice to drive the system into collapse, which often implies a large phase transition to the
disease state. When the system approaches the pre-disease state, the deviations of the set of nodes (3, 4, 7) increase drastically,
and the correlations (positively or negatively) among them also increase drastically whereas their correlations with other nodes
(1, 2, 5, 6) decrease drastically. We call (3, 4, 7) the DNB. (c) The disease state is the other stable state or a minimum of the
potential function, where the disease has seriously deteriorated and thus the system is usually irreversible to the normal state.
Claudius and who recognized the seemingly beneficial
effects of discharges from electrical fish in headache14.
Not astonishingly, these primitive neuromodulation
concepts gained much new interest in the 19th century,
when Emil du Bois Reymond—himself a migraine
sufferer—devised the first very precise instruments for
measuring and monitoring electrical biosignals and his
pupil Julius Bernstein developed the first membrane the-
ory of electrical resting and action potentials in neurons.
At the same time, driven by the industrial revolution
James Clark Maxwell invented closed-loop feedback to
control the speed of steam engines, which provides the
first theoretical framework that later led to the field
of cybernetics as the scientific study of “control and
communication in the animal and the machine”15. The
modern aspects of this field with some further notes on
the history have been recently described in the textbook
entitled “Neural Control Engineering: The Emerging In-
tersection Between Control Theory and Neuroscience”16.
In the following, we first briefly introduce dynamical
network biomarkers (Sec. II) and then adapt the concept
DNB to chronic disorders with episodic manifestations
(Sec. III) and highlight migraine as an example (Sec. IV).
To this end, we introduce migraine theories (Sec. V) and
computational models of spreading depression (Sec. VI)
on microscopic and macroscopic scale where the concept
of DNB must be applied. We end with an overview of
neuromodulation and concluding remarks (Sec. VII).
II. DYNAMICAL NETWORK BIOMARKERS
Traditional biomarkers are some objectively measured
and evaluated indicators of a particular biological state
that occurs in association with a pathological process.
Usually static measurements of some traceable sub-
stances are called biomarkers. Also genetic biomarkers
exist, defined as mutations or polymorphisms that pre-
dict some clinically relevant measure for example risk of
disease, its outcome or response rate to treatment.
In contrast, a DNB is a dynamical feature of a bio-
logical network under consideration. Such features were
originally suggested to be of particular interest in com-
plex diseases with sudden deterioration phases or critical
transition points during their progressions4,5. Depending
on the progression level of such disorders three stages are
distinguished: a normal state, a critical pre-disease state,
and a disease state (Fig. 1). The normal state is a steady
state with functional homeostatic control, representing a
(relatively) healthy stage yet maybe in an incubation pe-
riod. The critical pre-disease state is still clinically silent
and is considered as the state just before the first clini-
cal onset. Mathematically, the critical pre-disease state
is defined as the limit of the normal state immediately
before a well defined tipping point is reached. Finally,
the disease state is with control failure but otherwise, in
particular from a mathematical perspective, also simply
a stable state.
A DNB is essentially a group of traceable substances
or, in general, signals that while highly fluctuating are
strongly correlated only during the pre-disease stage.
Therefore a DNB is different from the conventional
biomarkers in two ways. First, it is not required for DNBs
to keep consistent values for the respective disease and
normal samples. Only the presence of highly fluctuat-
ing and strongly correlated signals is important. Second,
the aim of DNB is to detect the pre-disease state, i.e.,
early-warning signals associated with the imminent tip-
ping point, but not to distinguish the respective disease
and normal states.
If the pre-disease state is detected by a DNB, early
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FIG. 2. Possibly dynamical scenario of recurrent episodes as
a cycle (a)-(d) in chronic disorders (disease state) vs normal
state (e) described in pictorial ‘landscapes’. (a) interictal:
stable state where the disease under control; (b) prodrome:
when the state escapes over the potential barrier to a relative
flat plateau, the transient meta stable state is characterised by
a strongly fluctuating and correlated subnetwork (cf. Fig. 1);
(c) ictal: at a certain point, the episodes manifest in form
of a transient excursion that is recovered in (d) postdrome
(possibly changed landscape); (e) normal state remains stable
because the potential barrier toward th ictal state is too high.
(f) Additional premonitory symptoms such as migraine aura
or aura in epilepsy indicates the existence of different plateaus
(cf. Fig. 3). (g) Chronification of diseased state: landscape
changes such that the attack state persists.
treatment can be started, see Fig. 1. It was first analyti-
cally shown that a DNB serves as an early-warning signal
by defining particular but rather abstract critical states
as coherent subnetworks that were then recognized as the
physiological correlate of the pre-disease state. DNBs
were successfully identified in medicine for lung injury
disease, liver cancer, and lymphoma cancer4,5.
III. CHRONIC DISORDERS WITH EPISODIC
MANIFESTATIONS — DYNAMICAL SYSTEMS
THEORY VIEW
The idea of a transition in form of a sudden deterio-
ration from the health to the disease state via a specific
pre-disease state can be transfered to the cycle of recur-
rent episodic symptoms in chronic disorders. The pre-
disease state corresponds there to the prodrome, a stage
that is relatively clinically silent but subtle symptoms an-
nouncing the ictal phase. It is worthwhile noting that the
theoretical concepts are completely independent of the
application and can be transfered to various complex sys-
tems. Early-warning signals near tipping points exist in
systems ranging from medicine to financial market (and
their crashes), to power grid systems to which a large
amount of renewable energy is introduced, to ecosystem,
and to the global climate system3.
Many common neurological and psychiatric disorders
fit into the category of chronic disorders with episodic
manifestations including not only migraine and epilepsy
but also stroke, multiple sclerosis, sleep-wake disorders,
addictive disorders, schizophrenia and depression. But,
it remains to be investigated which are likely candidates
for dynamical diseases, which, we define here, accompany
abrupt changes in natural rhythms in some organ systems
due to bifurcations.
The existence of a prodrome with subtle symptoms
before the ictal phase is a promising indicator of such
a mechanism based on a bifurcation that shows early-
warning signals. A prodrome stage is actually what
would be expected from DNB being a subnetwork that is
both highly fluctuating and strongly correlated but still
in the physiological range. So let us consider again the
two ways described before in which DNB are different
from conventional biomarkers. If the concept is trans-
fered to chronic disorders with episodic manifestations,
DNB are by definition only present during the prodrome.
Therefore, the DNB should be considered as the neural
correlate of the prodrome. In other words, the existence
of DNB is not a prediction in these cases but rather one
possible a posteriori explanation for the prodrome.
The cycle of recurrent episodic manifestations is illus-
trated in a simplified way in Fig. 2. The states are as-
sociated to a potential function with a steady state or a
minimum of this potential function corresponding to the
attack-free interval and a prodrome phase corresponding
to a plateau level, which can be reached by spontaneous
fluctuations that are able to escape the potential bar-
rier from the minimum level to the plateau level. At
the far end of the plateau level, the ‘ictus’ is marked as
the state that initiates the attack. The plateau leads to
long transients and DNB dynamics, see also Fig. 3. Long
transients dynamics were for example also suggested in
a neural mass model of epileptogenic tissue17. However,
another possible landscape is that of a bi-stable regime,
for example, the dynamics of epileptic phenomena were
determined from statistics of such ictal transitions with-
out occurrence of a prodrome phase and DNBs18.
For a DNB being possibly an a posteriori explanation
for the prodrome sets the aim expressed by the second
difference bewteen DNB and classical biomarkers (see
Sec. II) into a broader perspective. While in complex dis-
eases with sudden deterioration phases the aim of DNB is
to detect the pre-disease state, now in chronic disorders
with episodic manifestations the question is what is the
neural correlate, i.e., what is the DNB, of the prodrome?
The aim could still be to more reliably detect the pro-
drome stage. However, migraine patients, for example,
already very often can correctly predict upcoming attacks
by their premonitory prodromal symptoms19. Thus, the
broadened aim is to use the understanding of the slow
and still gradual physiological changes in the prodrome
to prevent the imminent abrupt attack, that is, to quan-
tify the prodrome by DNB to construct a biofeedback
4nucleation
critical
nucleation
critical
neg. curvature
lower threshold
pos. curvature
stabilization
critical
slowing
down
dynamical network
biomarkers in
auraphase
localized
structures
mechanism
reaction-diffusion of
activator-inhibitor type
mechanism
+ cortical folding
mechanism
+ mean field inhibition combined mechanism
a b
c d
FIG. 3. Schematic illustration of the ‘landscape’ in a macro-
scopic model of SD (for details see Sec. VI B). (a) Reaction-
diffusion systems describe excitable media that support trav-
eling waves and can engulf a cortical hemisphere. (b) Corti-
cal folding modulates the pattern forming features. (c) Addi-
tional mean field control can stabilize localized SD structures.
(d) A critical slowing down of localized SD structures is ob-
served in a model with large mean field feedback control and
the patterns are modulated (breathing spots) in curved ge-
ometries.
signal for therapeutic control techniques.
IV. PRIMARY HEADACHES AS EXAMPLES
The theoretical concept of early-warning signals is in-
dependent of its application3 and the concept of DNB is
actually a model-free concept4,5. Still specific computa-
tional models are needed to approach the broadened aim
of therapeutic strategies. We cannot outline the potential
use of DNB as early-warning signals in general terms and
therefore focus on primary headaches and in particular
on migraine. Migraine patients can very often correctly
predict with premonitory symptoms their attacks19 and
various neuromodulation methods are today available to
treat headaches13. Furthermore, computational models
of migraine exist and describe the complex processes on
a wide range of time and space scales, see Fig. 4.
Migraine is a primary headache disorder characterized
by recurrent episodes of head pain, often throbbing and
unilateral sometimes preceded by neurological symptoms
called aura. The known pathophysiologic mechanism
suggests that this disorder should be considered as a neu-
rovascular headache20. Migraine is a highly disabling dis-
order being according to the World Health Organization
the seventh most disabling in the world and the fourth
most disabling among women. Cluster headaches are also
a primary headache disorder and the brainstem struc-
tures and subnetworks discussed below are also involved
in cluster headache so that these concepts can likely be
applied in some form to cluster headache, too.
Note that migraine is a chronic disorder with episodic
manifestation, also referred to as episodic migraine, while
the relative new term ’chronic migraine’ (CM) refers to
chronification of the recurrent attacks, that is, more then
15 headache days per month over a 3 month period, at
least 8 migrainous, and in the absence of medication
overuse.
In migraine without aura (MO), attacks are usu-
ally associated with nausea, vomiting, sensitivity to
light (photophobia) and sound (phonophobia), and at-
tacks are worsened by movement. Migraine with
aura (MA) involve in addition—but also rarely exclu-
sively—neurologic symptoms (called aura)21. Migraine
aura symptoms are most often visual field disturbances,
but affect also other sensory modalities or cognitive
functions22. Aura symptoms are caused by a wave of
cortical spreading depression. Whether this wave also
contributes to the headache phase in migraine is cur-
rently debated23. Epidemiological studies suggest that
MA and MO share the same headache phase, however,
on average the pain seems to be less severe and shorter
lasting in MA than in MO24.
The migraine cycle can be divided in four distinct
stages and the headache-free interictal interval. The pro-
drome is characterised by feeling tired and weary, diffi-
culty concentrating, yawning, polyuria, sweating, and fa-
tigue are some typical features19. It lasts up to one day
and occurs in about 60% of the reported cases. During
the aura phase, all kind of sensory disturbances, visual
most frequently, are reported. This phase lasts 5-60min
and occurs in about 30% of the reported cases. Migraine
headache is often unilateral and throbbing—though in-
terestingly from a dynamical systems theoretical point
of view, this seems to be not related to blood pulsation
but is a signature of rhythms in the brain25,26. Migraine
headaches last 4-72 hours and occur in about 95% of the
cases. Last, the postdrome is characterized by tiredness,
difficulty concentrating, weakness, dizziness, persistence
of sensitivity to light and noise, lethargy, and fatigue, to-
gether often described as ‘headache hangover’. It lasts a
few days and occurs in about 70% of the reported cases.
Together with the attack-free interval these phases com-
pose the migraine cycle with associated severe disabilities
and reduced quality of life even between attacks27.
V. MIGRAINE THEORIES
While we expect that quantitative methods such as
computational neuroscience will become increasingly im-
portant in migraine research to keep up with the prolif-
eration of imaging data and to confine current theories,
it was the advent of non-invasive imaging that changed
the view on this headache type in the first place with
some intriguing qualitative observations. In the 1980s
and into the mid-1990s, it became clear by studies of the
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FIG. 4. Migraine affects neural activities across all levels. (a) Rare monogenic subtypes exist and genome-wide association
study have revealed susceptibility loci for migraine with and without aura. (b) Disturbed functions of ion channel, proteins that
regulate them, and pumps can be modelled by ion-conductance-based models. (c) Neuronal subpopulations and local circuits
in specific brain regions, in particular, the layered cortex have also been investigated. (d) Higher-order networks of central
nuclei and peripheral ganglia form the migraine generator network and its dynamical state may change during the course of
an attack (e)-(f). (g) Sensory processing can be perturbed in particular during the aura phase and behavioral changes occur
in the prodromal such as food craving that can lead to false interpretation of triggers. (See main text for further detail.)
clinical features of migraine and its physiological mech-
anisms that there is no clear correlation between blood
flow changes and the headache but instead imaging stud-
ies suggested28 that upstream events in the brainstem
named ‘migraine generator’ (MG)29 lead to the cascade
resulting in migraine pain. Furthermore, imaging mi-
graine with aura revealed that the phenomenon of corti-
cal spreading depression (SD) is the neural correlate of
migraine aura30,31. To date, the MG and SD theories are
facing each other but are probably not irreconcilable.
In brief, the MG theory states that a dysfunction of the
brainstem causes the pain and via further connections
(directly and indirectly) the brainstem is also respon-
sible for the neurological changes before the headache
phase including symptoms in the prodromal phase and
the aura phase, in particular, the MG is causing SD via
a failure of vasomotor control (Fig. 4d). The SD theory
of migraine assumes that this cortical wave causes the
neurological systems (aura)32 and it can also cause the
pain in the headache phase, which usually occur after
the aura phase, but cf. Ref.33. In this theory, two inde-
pendent pathways of increased pain traffic are suggested,
a peripheral and a central pathway. The headache pain
can either be triggered by a local release of noxious or
6inflammatory substances during the hyperemic phase of
SD23,34. These substances are thought to be transmitted
outward in the direction perpendicular to the cortical
layers into the pain sensitive meninges. This transmis-
sion results in an activation of pain receptors (nocicep-
tors) and local inflammation, which eventually triggers
the migraine headache (peripheral pathway, Fig. 4e). Or
the alternative explanation is that SD leads to pain by a
corticothalamic feedback that affects sensory processing
by third-order neurons arising within the sensory tha-
lamus. This is supported by the efficacy of calcitonin
gene-related peptide receptor antagonists at the level of
these neurons in migraine therapy35 (central pathway,
Fig. 4f). Probably, a combination of the peripheral and
central pathway leads to this complex disorder and quan-
titative models as outlined below can help to disentangle
the relative contributions and dependencies.
VI. COMPUTATIONAL MODELS IN MIGRAINE
Computational models of spreading depression date
back to the mid 1970s. A simple rule-based cellular au-
tomata model was used to mimic the two-dimensional
spread on the cortical surface, including spiral-shaped SD
waves reentering around a functional block36 that can
also be observed experimentally37. Partial differential
equations were used to describe the detailed physiologi-
cal cellular events38. For a detailed review of modelling
SD including the mathematical description see the excel-
lent review by Miura et al.39. In the following, only basic
approaches focusing on the principles of cellular dynam-
ics and tissue pattern formation in SD are introduced.
We start with cellular dynamics of SD and continue with
the events in cortical tissue. The mathematical equations
are given in an Appendix.
A. Cellular dynamics in SD
The focus in computational models of the cellular dy-
namics in SD is on transmembrane events that can be
observed in in vitro experiments40. The advantage of
such experiments is that the phenomenon of SD can be
studied in isolation and the complex vasomotor feedback
involved in SD can be neglected41, though current mod-
elling approaches include metabolic and perfusion effects
on SD42. With this local focus set, SD is essentially a
massive but temporary perturbation of ion homeostasis.
The ion concentrations are under physiological conditions
kept within a narrow range and their gradient across the
cell membrane is treated in traditional computational
models of Hodgkin-Huxlex (HH) type as a constant bat-
tery, the reversal potential or Nernst potential43. During
SD, however, ion concentrations can change by over one
order of magnitude, so that the original HH approach
to describe the potential changes across the excitable
membrane must be extended. For instance, during SD
the extracellular potassium concentration raises from
3mM within a few seconds to peak values around 55mM,
plateaus at this level for about 30 seconds and recovers to
the physiological range within one to two minutes32. Fur-
thermore, neuronal activity is depressed due to the nearly
complete elimination of the transmenbrane ion gradients,
in other words, the cells release almost all of their avail-
able energy—the Gibbs free energy—the supply for phys-
iological neural activity44. This depressed activity state
can spread throughout gray matter in the brain, hence
this activity is named as SD (see below the section on
spatial patterns forming in cortical tissue).
To model local cellular events in SD, Kirchhoff’s
current law is used as first introduced in the HH
framework43. The major extension, however, is that in
addition to the original transmembrane potential V and
the variables activating and inactivating conductances of
transmembrane channels (voltage-gating variables, usu-
ally called m, n, and h) further functions and dynamic
variables for the ion homeostasis are introduced. First,
an ATP driven ion pump is modeled that exchanges in-
tracellular sodium ions with extracellular potassium at a
3/2 ratio and therefore changes not only ion concentra-
tions dynamically but also leads to a depolarizing trans-
membrane current Ipump. Second, extracellular and in-
tracellular ion concentrations become dynamic variables
and thus increase the phase space of the model. We re-
fer to the Appendix A for the corresponding mathemat-
ical equations. Such an extended framework is able to
model the long lasting dynamics on time scales of min-
utes, while, for example, a single action potential, which
is described in the first generation HH-type framework,
lasts about a millisecond, a time scale separation of about
five orders of magnitude. This new time scale separation
is the fundamental characteristic of this second genera-
tion HH-type framework.
The first generation of HH-type models for single cells
are also called conductance-based models. In the parallel
development of neural mass models for cell populations
one often refers to rate- or activity-based modelling. In
each case, the model is named after the respective depen-
dent dynamical variables other than the transmembrane
potential. In this terminology, the second generation HH-
type models necessary to model SD are ion-conductance-
based models. Note that ion-conductance-based models
are necessarily ‘tissue-embedded’ single cell models be-
cause the amount of cell membrane surface area per unit
tissue volume, in short, the surface area-to-volume ratio
plays a significant role. While this factor does not affect
HH type conductance-based models, in ion-conductance-
based models it gives rise to the long time scale of SD
excitation cycles as compared to much shorter actions
potentials and may likewise cause slow modulations of
activity in extended rate- or activity-based neural mass
models.
With an ion-conductance-based model of a total of 9
dynamical variables the main features of SD that hap-
pen across the cell membrane can be modelled (see
7Fig. 4b). Using electroneutrality and further symme-
try constraints, ion-conductance-based models can be
further reduced and become amenable for bifurcation
and geometrical phase space analysis. On the other end
towards physiologically more realistic ion-conductance-
based models of SD, several dozens of dynamical vari-
ables in various electrically coupled neural compartments
(∼200, which effectively multiplies the number of de-
pendent dynamical variables) can be modelled in tissue-
embedded single cell models39,45–47.
Although in reduced ion-conductance-based models
the time course of the dynamic variables can be to
some extent distorted as compared to more realis-
tic models39,45–47, main features of SD are revealed
(Fig. 4b). Two phases and three points stand out because
of their significant mechanistic meaning in SD as an exci-
tation phenomenon: the seizure-like afterdischarges, the
subsequent excitation block, the begin of a INa+ -driven
transient repolarization, the m-gate deactivation that fi-
nally initiates a phase where the pump current Ipump can
become dominant, see Fig. 4b.
Of all these events highlighted in Fig. 4b most notably
is the recovery phase of SD at around ∼24.5s. Accord-
ing to the computational models, recovery is due to a
deactivation of the sodium activator m driven by a dom-
inate INa+ that actually repolarizes V shortly after the
seizure-like firing stops due to a depolarization block. Af-
ter the deactivation of the sodium activator m, the pump
current Ipump drives the membrane potential V (black)
for several seconds outside the window of the two reversal
potential of sodium and potassium, ENa+ (red) and EK+
(blue), respectively. The ignition of SD is due to a torus
bifurcation (not shown, unpublished results) of the tonic
seizure-like firing caused by the initial stimulation phase.
This suggests that after the offset of the stimulation at
0.5s the state of the dynamical system is already behind
a canard-like trajectory that serves as a threshold caus-
ing firstly a brief phase of sustained (2-3s) afterdischarges
and then a long lasting recovery phase during which the
system is refractory.
Next, we consider large-scale tissue events caused by
SD. But before that it is worthwhile noting that cellular
models often do not include lateral space, except for the
original work by Miura and Tuckwell38 and some recent
approaches from the group of Miura48 and an isolated
work by Shapiro46 considering osmotic forces and gap
junctions. The compartments mentioned before extend
in the vertical direction to model the apical dendritic
tree of pyramidal cells in the cortex45,47. But the very
detailed models by Kager, Wadman, and Somjen are not
spatially extended to describe the lateral extension, that
is, they describe SD not as an excitable phenomenon in
a spatially extended system, called excitable media.
The lateral extension of cellular SD models is far from
straight forward. Naively adding diffusion to the extra-
cellular dynamical ion concentrations yields some insights
but it does not reflect the necessary detail of neural mi-
crocircuits that needs to be considered to take the spatial
continuum limit (Fig. 4c). Neural field models, for exam-
ple, describe this limit for rate- or activity-based neural
mass models49. The problem is that the neural tissue
is heterogeneous and the cell’s embedding needs to be
considered in quite some detail for a lateral extension
of cellular SD models. A bottom-up approach toward an
ion-conductance-based medium model that lacks the sup-
port of an effective medium theory cannot expand from
membrane to tissue level in a canonical way and therefore
loses its advantage over the simpler top-down approaches.
Likewise, a coarse-graining in time from individual spik-
ing to rate or activity-based dynamics in simulated cell
populations is needed for the relevant time scales in mi-
graine. A first promising approach was made with an
ion-conductance-based model in seizure spread50.
B. Tissue events caused by SD
The Gibbs free energy-depleted and activity depressed
state of SD described in the former section can spread
through gray matter tissue by electrodiffusion due to
newly formed ion gradient along the membranes in the
neuronal and glial syncytium and the interstitial volume.
In accordance with noninvasively imaged SD progression
using high-field functional magnetic resonance imaging
(fMRI)31 and reported visual field defects51, a macro-
scopic computational model of SD (see Appendix B) was
proposed in which to each episodic migraine attack a par-
ticular spatio-temporal SD pattern is formed12,52. With
this model a mechanism was suggested to explain the
shape of SD in migraine as a discontinuous wave seg-
ment that spreads out in only one direction. In a nut-
shell, the mechanism is based on dissipative structures
as self-organized localized solitary patterns53,54 that be-
come transient objects with critical slowing down—from
a mathematical point of view a mechanism similar to the
one of DNB—that is modulated by cortical folding, see
Fig. 3.
These are the tissue events of SD that are of clin-
ical importance for migraine because we predict that
they will determine not only the migraine aura but also
the headache phase for two reasons. First, the spatio-
temporal patterns of SD determine via the peripheral
pathway (Fig. 4e) the transmission of noxious or inflam-
matory mediators in the direction perpendicular to the
cortical surface into the pain sensitive meninges. This
transmission must be significantly convergent to reach
noxious threshold concentrations, whereby likewise the
considerable heterogeneity of increased nociceptor den-
sity around pial arteries and dural venous sinuses can
interfere with the distinctive self-organized patterns in
the folded cortex. Second, the particular spatio-temporal
pattern of SD probably also determines via the central
pathway the specific corticothalamic feedback that affects
sensory processing in terms of sensitisation by third-order
neurons (Fig. 4f). We suggested that the two major mi-
graine subtypes, MO and MA, depend on the spatial SD
8patterns and the bifurcation that is responsible for their
transient nature one being without critical slowing down
and one showing critical slowing down, respectively12,52.
The major advantage of generic, i.e., low dimensional,
reaction-diffusion models of SD lies in the fact that they
provide insight in the phase space structure of the whole
class of models they represent. In fact, localized soli-
tary patterns are not the only SD waves in the human
cortex of clinical relevance. Re-entrant SD waves are be-
lieved to have the potential to worsen stroke outcome
in incremental steps with each wave circling near the
infarct core, while the same SD wave in the penumbra
zone far from the infarct tissue could also have a ben-
eficial component by stimulating blood flow55. The in-
farct core is a static anatomical block, whereas spiral
waves and localized SD waves in migraine have a vari-
able core (functional block) and variable left-off tissue,
respectively37,56. These and other clinically important
spatial pattern forming mechanisms can be understood
in terms of phase space structures. These structures de-
scribe the migraine aura–ischemic stroke continuum as
transitions of two-dimensional wave pattern in SD from
retracting localized (migraine) to stationary waves (per-
sistent migraine aura without infarct) to re-entrant waves
(stroke)57. Therefore, the precise spatio-temporal SD
pattern formation is of immense clinical interest58.
To simulate the clinically observed patterns in
migraine31,51, a generic reaction-diffusion mechanism can
be described in abstract terms of activator-inhibitor ki-
netics. In fact, simple activator-only kinetics date back to
a mechanism of SD described in 1963 by Grafstein based
on an otherwise unpublished suggestion by Hodgkin and
Huxley, to date called the Grafstein-Hodgkin-Huxley
(GHH) model59. The GHH model assumed that the
extracellular potassium ion concentration is an activa-
tor in SD. We extended this scheme by introducing two
inhibitory mechanisms, an immobilized inhibitor and a
mean field inhibition (for details of the full model see
Ref.52).
The abstract activator and inhibitor variables are lump
variables. Unlike in the original GHH model, it is not
necessary or even possible to identify particular physi-
ological quantities, like [K+]e, with them. Instead, the
activator should be viewed as a positive feedback element
with a bistable energy state. The activator and inhibitor
or rather the respective networks of dynamical variables
that constitute these elements can be described in great
physiological detail on the cellular level (see the former
section) yet they are also new emerging conceptual quan-
tity that allows us to describe the phenomenon of SD di-
rectly on the macroscopic level. The high energy state
(a stable fixed point) corresponds to the maintenance of
homeostasis far from thermodynamic equilibrium and the
low energy state (another stable fixed point) to the state
where the cellular Nernst reversal potentials are elim-
inated, that is, a state at or near the thermodynamic
Donnan equilibrium44. In the presence of inhibitors as
recovery variables, which were not included in the GHH
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FIG. 5. Various neuromodulation techniques are currently
investigated in chronic migraine, but note that, as of to date,
there is no approved indication for neuromodulation with elec-
tric or magnetic stimulation for episodic migraine. We suggest
to investigate these techniques also in episodic migraine and
to use quantitative models and modern control theory to de-
termine an optimal stimulation protocol, target structure and
phase within the migraine cycle. Photograph top left (SPG
stimulation): courtesy Autonomic Technologies, Inc. c© 2013.
Inset figure top right: courtesy of STX-Med c© 2013. Pho-
tograph bottom right (TMS device): courtesy of Neuralieve,
Inc. c© 2013 (trading as eNeura Therapeutics).
model, the low energy stable fixed point becomes a tran-
sient state that can, however, spread through gray mat-
ter tissue by electrodiffusion as a depleted and activity
depressed state.
VII. CONCLUDING REMARKS ON TRANSLATING
THEORETICAL CONCEPTS INTO
NEUROMODULATION APPLICATIONS
The design of new neuromodulation strategies in mi-
graine requires to understand how electric and magnetic
stimulation changes neural activity. Even more impor-
tant are quantitative models of the network dynamics
during this neurological condition to optimize stimula-
tion protocols. In Sec. VI A, we described cellular dy-
namics that are key to understand how electric and mag-
netic stimulation influences brain activity. The cellular
dynamics are also the microscopic foundation of self-
9organized macroscopic tissue events, which are of di-
rect clinical relevance. In Sec. VI B, we show that on
the macroscopic level SD manifests as a localized wave
in the human cortex during migraine with aura. From
the model we can predict that the macroscopic spatio-
temporal SD patterns (shape, size, and duration) deter-
mine to some extent the clinical manifestation of a mi-
graine attack12.
As we argued in Sec. V, the spatio-temporal SD events
can determine the amount of noxious input into the pain
sensitive structures (Fig. 4e) as well as modulate corti-
cothalamic feedback loops (Fig. 4f). However, the ques-
tion about the most upstream event in the course of a
migraine attack that would directly lead to the optimal
target of preventative intervention is probably too naive.
The ignition of SD is currently unknown but a failure
of vasomotor control from the brainstem, which is part
of the MG theory, is a likely scenario (Fig. 4d). It fur-
ther is plausible that these SD waves will in turn also
affect the brainstem activity because SD itself causes a
complex vasomotor reaction41. This allows only one con-
clusion: Migraine is an inherently dynamical disease with
a complex network of interdependent events rather than
a disease with a linear course from upstream to down-
stream events, a course that is also called into question
by a rather variable cycle of recurrent episodic symptoms
in migraine with phases such as the aura that occurs only
in a fraction of the individual attacks60.
The central question therefore is about different brain
structures and in which phase of the migraine cycle they
are promising neuromodulation targets (Fig. 5) in the
framework of complex dynamical systems and control
theory8. We still lack a unified quantitative model com-
bining the events in SD theory and MG theory of mi-
graine (Sec. V) to interpret their relation, simulate the
impact of potential neuromodulation intervention, and
make concrete predictions about optimized stimulations
protocols that can be tested. In this situation, however,
the theoretical framework of DNB provides a sound ba-
sis to address these challenges because DNB are based
on a model-free concept and, if DNB can be identified
in migraine, they will help to develop a unified theory.
Namely, DNB will not only show whether a symptom
is approaching or not, but also help to construct such
a unified model explaining how the symptom appears,
and providing a feedback-control-scheme to suppress the
symptom.
We end this review by introducing briefly two neuro-
modulation techniques that are currently investigated in
migraine in two different phases of the migraine cycle
targeting two different brain structures. Then, we specu-
latively suggest a promising third neuromodulation tech-
nique that may be of particular use during the prodromal
phase that could reflect a DNB (cf. Sec. III). Further-
more, we also suggest taking the attack-free interval into
account for prophylactic intervention.
Note that, as of to date, there is no approved indica-
tion for neuromodulation with electric or magnetic stim-
ulation for episodic but only for chronic migraine (>15
headache days per month). In fact, due to the severeness
of pain, most neuromodulation studies in headache re-
search are or have been conducted among patients with
refractory cluster headache. However, the field is rapidly
increasing13 and given that newer devices require non-
invasive or minimally invasive implant surgery involv-
ing a new generation of intelligent control methods also
less disabled patients with high frequency epsisodic mi-
graine with unsatisfactory treatment response could ben-
efit from efficient neuromodulation.
A. Transcutaneous electrical nerve stimulation
Transcutaneous and transcranial (see the next subsec-
tion) stimulations are the two noninvasive modes cur-
rently at hand. The transcutaneous electrical nerve stim-
ulation (TENS) modulates neural activity by targeting
noninvasively peripheral nerves. In migraine, a supraor-
bital transcutaneous stimulation (STS) was tested with
a portable device that looks like a silver headband and
targets the ophthalmic division of the trigeminal nerve
that terminates in the central trigeminal nucleus caudalis
(TNC) and the C1-C2 regions of the cervical spinal cord,
together known as the trigeminocervical complex (TCC),
see top right in Fig. 5.
In a recent study, the stimulation was tested with
biphasic rectangular AC impulses at 60Hz. The ther-
apeutic gain (26%) is within the range of those re-
ported for other preventive drug and nondrug antimi-
graine treatments61. The mode of action or even quan-
titative methods to test paradigms are currently miss-
ing, though it seems plausible that if central sensitiza-
tion of second-order neurons is causing migraine pain,
this method is suppressing the inbound sensory traffic
which could add to sensitization, and it should therefore
be used in the acute headache phase rather than prophy-
lactically.
B. Transcranial magnetic and electrical stimulation
The transcranial stimulation targets not peripheral
neurons but the cortex. Two noninvasive neuromodu-
lation techniques are available in migraine, transcranial
magnetic stimulation (TMS) and transcranial electrical
stimulation (TES). A recent carefully sham-controlled
larger trial with a portable TMS device was undertaken
as a promising noninvasive neurostimulator for disrupt-
ing SD early in the aura phase62, see bottom right in
Fig. 5. The results (effective in aborting migraine at-
tacks) of this sham-controlled study were promising, i.e.
it seems to disrupt SD, but that would limit its use to
the acute aura phase. However, considering the concept
of silent aura63 and the mathematical model for SD52,
TMS could potentially be effective when used in the very
early headache phase targeting the shorter lasting phase
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of SD. In either case, there is a clear need for further
studies and the optimization of the stimulation protocol
for targeting localized spatio-temporal reaction-diffusion
patterns52.
The simplest technology with the least safety issue is
probably TES. Two versions of TES exist, the transcra-
nial direct current stimulation (tDCS), in which cathodal
tDCS inhibits while anodal tDCS increases neuronal fir-
ing. The alternating current stimulation (tACS) has not
yet been clinically tested in migraine. Preliminary evi-
dence was found for patients with chronic migraine hav-
ing a positive, but delayed, response to tDCS applied to
motor (anodal) and oribitofrontal (cathode) cortices64.
In addition, computational simulations of current flow
through brain regions were used to interpret the effects
in this study. With the help of such simulations, a prin-
cipal understanding of pain modulation can be gained,
whether this modulation is due to the effect of TES on
SD or on the dynamics of the pain matrix and deeper
structures including thalamus and brainstem. Effective
prophylactic therapy in migraine was also studied with
cathodal tDCS over the visual cortex with the anode
overlying the motor and sensory cortices65.
C. Sphenopalatine ganglion stimulation
Beside the two mechanism explained by the SD the-
ory (Fig. 4e,f), also other mechanisms could activate
pial and dural nociceptors and trigger the pain of the
headache phase of migraine. It was suggested by Burstein
and Jakubowski66 that a common pathway for various
migraine triggers could be provided by the pre- and
postganglionic parasympathetic neurons in the superior
salivatory nucleus (SSN) and sphenopalatine ganglion
(SPG). A number of projections converging in the SSN
seem to be coming from brain areas that can explain typ-
ical migraine triggers, for example stress, dietary, and ex-
ternal stimuli such as smell. Targeting the SSN through
antidrome or feedback mechanisms of the SPG could
therefore be a potential target in migraine (prevention).
Interestingly, it was also argued that for many if not
all of the typical triggers the role of cause and effect is ac-
tually reversed and premonitory symptoms are mistaken
as triggers67,68. For example, eating chocolate, as a typ-
ical food craving symptom before the headache phase of
migraine, is a brain-driven response within the premon-
itory phase and not a trigger, i.e. the cascade of the
attack has already started and the only symptom at that
stage is the craving with all the other symptoms still to
come. Likewise, sensitivity to light (photophobia) dur-
ing the premonitory phase could mistakenly identified as
a trigger by light. In the context of DNB this is certainly
plausible as this concept predicts a common subnetwork
such as SSN and SPG to be involved in the premonitory
symptoms.
Given the theory that the pre- and postganglionic
parasympathetic neurons in the superior salivatory
nucleus (SSN) and sphenopalatine ganglion (SPG) could
be a common pathway for migraine triggers66, minimally
invasive sphenopalatine ganglion stimulation might be
suited in particular in the prodromal phase in episodic
migraine. An very innovative implantable battery-free
SPG stimulator has been developed to apply on-demand
stimulation for the treatment of migraine and other
primary headache69. In a pilot study (n=11), the
potential of electrical stimulation of the SPG has already
been shown in attack abortion, 2 patients were pain-free
within 3 minutes of stimulation, 3 had pain reduction, 5
had no pain relief, 1 was not stimulated70. However, in
this pilot study, the headache was allowed to intensify
up to 6 hours before stimulation was initiated, where
SPG stimulation might theoretically be less efficient
to influence a migraine attack than it could have in
the prodromal phase. More to the point, a recent
paper described not only a marked abortive but also a
preventative effect in cluster headache patients71 which
could best be explained by feed-back mechanisms from
the SPG to the SSN and thus underlining the above
mentioned theory and pointing towards the SPG as a
suitable target for attack prevention. However, all this
is based on a theoretical concept and it should be noted
that in migraine research no valid studies have been
published yet to prove that SPG stimulation could have
a positive effect in this syndrome as well.
To summarize, already to date various neuromodula-
tion methods for treatment of primary headache have
been studied, beside the above mentioned also other
invasive techniques such as deep brain stimulation and
minimally invasive occipital nerve stimulation13. To
fully realize the potential of computational models that
can be translated into a new neuromodulation paradigm
a modern control theory is needed. The challenge in the
future will be to integrate the known mechanisms into a
tractable theoretical migraine model, but also to obtain
human data from clinical studies and identify DNB.
Therefore, new clinical study designs are needed to
investigate the macroscopic dynamics in migraine. For
example, fMRI brainstem specific ROI-based imaging
paradigms and fluorodeoxyglucose positron emission
tomography (FDG-PET) combined with magnetic
resonance imaging (MRI) could identify important
neuronal centers in the brainstem and describe their
connectivity pattern72. Such imaging methods together
with quantitative methods and theoretical concepts are
important to characterize dynamics in the migraine gen-
erator network and identify DNB over several migraine
cycles in controls and patients suffering from episodic
migraine.
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VIII. APPENDIX: MODEL EQUATIONS
A. Cellular models
To model local cellular events during SD, we start with
Kirchhoff’s current law that was introduced as an equiv-
alent membrane circuit by Hodgkin and Huxley43
dV
dt
= − 1
Cm
(INa+ + IK+ + ICl + Ipump − Iapp). (1)
The variable V is the potential difference or voltage
across the membrane relative to the grounded extracel-
lular side. The cell membrane has a capacity Cm. The
currents Iion are the transmembrane currents with ion
∈ {Na+,K+, Cl−}. Iapp is an externally applied cur-
rent.
In the original HH framework, an unspecified leak cur-
rent was modelled but not a chloride current. The major
extension, however, is the pump current Ipump, which
can be modeled for example as73:
Ipump(Nai,Ke) = ρ
(
1 + exp
(
25−Nai
3
))−1(
1 + exp (5.5−Ke)
)−1
. (2)
The pump current Ipump with pump rate ρ describes the
ATP driven exchange of intracellular sodium ions with
extracellular potassium at a 3/2 ratio.
The ion concentrations [ion] change due to fluxes pro-
portional to the ion currents. The additional rate equa-
tions for intracellular ion concentrations are
d [ion]
dt
= − γ
ω
(Iion + αIpump) , (3)
with α being 3, 2, and 0 for Na+,K+, and Cl−, respec-
tively. The parameter γ converts currents to ion fluxes
and depends on the membrane surface area Am and Fara-
day’s constant F , γ = AmF . The parameter ω is the vol-
ume of the intracellular space (ICS).
In addition, also dynamical gating variables n, h and
m have to be introduced, as in the original HH model.
The potassium activator, sodium activator and sodium
inactivator are defined by the voltage-dependent gating
dynamical variables n, m and h, respectively. These are
given by
d p
dt
=
1
τp
(p∞ − p) , (4)
for p ∈ {n,m, h}.
B. Reaction-diffusion models
To simulate the clinically observed patterns in
migraine31,51, a generic reaction-diffusion mechanism can
be described in abstract terms of activator-inhibitor ki-
netics of just two variables u and v, respectively. We
extended the GHH model (see the main text) in the fol-
lowing way (also for details of the full model see Ref.52):
ε
∂u
∂t
= u− 1
3
u3 − v +∇2u, (5)
∂v
∂t
= u+ β +K
∫∫
H (u) dxdy, (6)
with H being the Heaviside step function and the space
coordinates are given by x and y. Both activator u and
inhibitor v are lump variables (see the main text). We
set the parameter as follows: time scale separation ε =
0.04, the threshold β = 1.32, and the mean field coupling
K = 0.003.
There are two stable solutions of this model, namely
the homogeneous steady state and the traveling wave.
Moreover, there exists a saddle solution forming a local-
ized solitary pattern whose stable manifold is the basin
boundary of the stable solutions. By varying a control
parameter, the stable traveling wave solution and the
saddle solution collide causing the saddle-node bifurca-
tion. The saddle-node bifurcation and the critical slowing
down with this model suggest the applicability of DNB
to detect SD.
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